Physician

Angelo Markatos, D.O.

According to 2025 Medicare claims, Angelo Markatos, D.O. (NPI: 1447279245) practices nephrology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Ocean, NJ. This provider's primary affiliated billing organization is NORTHEAST KIDNEY CARE LLC (NPI: 1023889565; TIN: 933742471) and primary practice location at 08050-2483.

Markatos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 865 traditional Medicare patients, billed 3,186 HCPCS/CPT codes, and received $276,699 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,691 prescription claims across 402 beneficiaries totaling $425,462 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 239 claims. Open Payments data shows 42 records totaling $1,301. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,223	3,623	$338,603
2016	1,194	3,389	$313,439
2017	1,050	2,997	$291,349
2018	1,085	3,167	$308,795
2019	1,015	3,403	$302,240
2020	901	3,103	$256,842
2021	1,036	3,330	$336,136
2022	1,018	3,472	$311,989
2023	921	3,757	$314,834
2024	865	3,186	$276,699

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	355	2,305	$217,071
2016	384	2,558	$258,936
2017	350	2,458	$262,637
2018	356	2,517	$279,819
2019	365	2,501	$272,633
2020	331	2,293	$209,752
2021	328	2,217	$212,725
2022	351	2,299	$193,248
2023	375	2,459	$343,232
2024	402	2,691	$425,462

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	435	$41,500
2016	N/R	428	$31,623
2017	N/R	314	$19,212
2018	N/R	281	$15,588
2019	N/R	215	$11,939
2020	N/R	188	$11,949
2021	N/R	246	$12,982
2022	N/R	232	$5,812
2023	N/R	253	$4,913
2024	N/R	239	$3,749

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	221	246	$138
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	297	504	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	346	807	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	46	54	$64
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	226	435	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	170	9,840	$178,400
Jardiance	Empagliflozin	53	2,850	$50,487
Kerendia	Finerenone	40	2,380	$50,002
Veltassa	Patiromer Calcium Sorbitex	49	1,805	$45,060
Lokelma	Sodium Zirconium Cyclosilicate	20	840	$19,156

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	86	$1,901
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	80	$966
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	51	$866
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	22	$16

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$1,301	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Angelo Markatos, D.O.?

Tedicare shows public-source Medicare data for Angelo Markatos, D.O. (NPI 1447279245), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Angelo Markatos, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Angelo Markatos, D.O.?

Angelo Markatos, D.O. is linked to NORTHEAST KIDNEY CARE LLC (billing NPI 1023889565) in the available physician profile data.

Does Angelo Markatos, D.O. have Open Payments data?

Angelo Markatos, D.O. has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.